Vivos Therapeutics closes acquisition of an 11% fully diluted stake in SOD Sciences and a 50% interest in its Pseudohypoxia Test, with potential access to more than 325,000 patients through the AHA channel

Observed price moves

• VVOS+7.09%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.